The Danish drugmaker will start selling a pill version of its Wegovy weight-loss medicine in January, after [securing ...

The FDA has approved the oral version of Novo Nordisk’s injectable weight loss drug Wegovy, making it the first GLP-1 pill to ...

Eli Lilly is pursuing its own oral version of its obesity drug Zepbound. The Indiana-based company operates two new campuses ...

Hyderabad: Global pharma heavyweights Eli Lilly and Novo Nordisk are racing to lock in market leadership in India’s blooming ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

Danish pharmaceutical multinational Novo Nordisk is expanding its presence in inherited blood disorder treatments ...

European shares briefly hit a record high on Tuesday, powered by gains in the healthcare sector, after heavyweight Novo ...

Regulators approved the first-ever GLP-1 pill for treating obesity from Novo Nordisk. Alphabet will acquire data center ...